Support for you as you pursue your goal
Talking with your doctor about Vimpat shows you have a desire to pursue a life with fewer interruptions from partial-onset seizures. But adding a medication and sticking with a treatment plan isn't always easy. So Vimpat offers the Vimpat Advantage Program, a FREE patient support program with savings, knowledge, and community to empower you as you work toward your goal.
When you sign up for the Vimpat Advantage Program, you'll receive:
- Savings—Save on your Vimpat prescription with a 14-day FREE Trial Voucher and a Savings Program Card worth up to $45 off each prescription co-pay, every month for 1 year
- Knowledge—Gain the confidence to take control of your treatment with the knowledge you get from information-packed emails about epilepsy and treatment
- Community—Connect with others going beyond okay. Your free subscription to EpilepsyAdvocate magazine connects you to a community of people striving to live well with epilepsy.
- Talk to your doctor about VIMPAT to see if it’s right for you.
- Who's Eligible for Savings?
Most patients who have commercial prescription insurance can benefit from the Vimpat Savings Program. If you have any questions regarding your eligibility or benefits or if you wish to discontinue your participation, call the Vimpat Savings Program at 1-800-657-7613 (8:00 am – 8:00 pm EST, Monday–Friday).
- Who's Not Eligible for Savings?
Patients receiving prescription reimbursement under Medicare, Medicaid, and similar federal or state programs are not eligible for the 12-month discount. This includes patients who are enrolled in a Medicare Part D prescription drug program. Additionally, this program is not valid where prohibited by law.
Vimpat® (lacosamide) is a prescription medicine that is used with other medicines to treat partial-onset seizures in people 17 years of age and older with epilepsy.
Important Safety Information
Vimpat may not be for everyone. Ask your healthcare provider if Vimpat is right for you.
Warnings and Precautions
Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before.
Do not stop taking VIMPAT without first talking to your healthcare provider. Stopping Vimpat suddenly can cause serious problems. Stopping seizure medicine suddenly in a patient who has epilepsy can cause seizures that will not stop.
Vimpat may also cause you to feel dizzy, have double vision, feel sleepy, or have problems with coordination and walking. You should not drive, operate machinery or do other dangerous activities until you know how Vimpat affects you.
Vimpat may cause you to have an irregular heartbeat or may cause you to feel faint. Call your healthcare provider if you have a fast, slow, or pounding heartbeat, shortness of breath, feel lightheaded, or if you fainted or feel like you are going to faint.
Vimpat is a federally controlled substance (C-V) because it can be abused or lead to drug dependence. Keep your Vimpat in a safe place to protect it from theft. Do not give it to anyone else, because it may harm them.
In rare cases, Vimpat may cause a serious allergic reaction that may affect your skin or other parts of your body such as your liver or blood cells. Call your healthcare provider right away if you have a skin rash or hives, fever or swollen glands that do not go away, shortness of breath, swelling of the legs, yellowing of the skin or whites of the eyes, or dark urine.
Before taking Vimpat, tell your healthcare provider if you have or have had depression, mood problems, or suicidal thoughts or behavior; have heart, kidney or liver problems; have abused prescription medicines, street drugs or alcohol in the past, are pregnant or plan to become pregnant.
Vimpat® oral solution contains aspartame, a source of phenylalanine.
Common Adverse Reactions
In clinical trials, the most common side effects seen with Vimpat were dizziness, headache, nausea, and double vision.
Talk to your healthcare provider about other possible side effects with VIMPAT. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see additional patient information in the Patient Medication Guide. This information does not take the place of talking with your healthcare provider about your condition or your treatment.